- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy: Study

Longer lifetime exposure to female hormones may increase the risk of thyroid cancer in women, according to a study being presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago, Ill. The research suggests reproductive and hormonal factors may be involved in thyroid carcinogenesis.
Thyroid cancer occurs more frequently in women than in men, but the reasons for the increase remained unknown. Scientists from the College of Medicine at The Catholic University of Korea in Seoul designed research to find out why. They conducted a nationwide population-based study of approximately 5.7 million women aged 40 years or older, using data from the Korean National Health Insurance Service, the program that provides universal health coverage.
The study population had participated in breast and cervical cancer screening programs between 2010 and 2011, where they shared reproductive health details using standardized questionnaires. The women were followed until the diagnosis of thyroid cancer, death or the end of follow-up in 2023. Associations between reproductive factors and the incidence of thyroid cancer were evaluated using Cox proportional hazards regression models. Multivariable models were adjusted for age, smoking status, alcohol consumption, regular physical activity, body mass index, hypertension, diabetes, dyslipidemia, history of cancer and household income levels.
The scientists found that about 2.4 out of every 1,000 people per year develop thyroid cancer. A longer reproductive span was associated with a progressively increased risk of thyroid cancer. Use of hormone replacement therapy (HRT) was also associated with an increased risk of thyroid cancer, with a stronger association observed among women who received HRT for five years or more.
"These results show how common life events in women, such as the timing of menopause and use of hormone therapy, may influence cancer risk," said Jinyoung Kim, M.D. Ph.D., assistant professor in the College of Medicine at The Catholic University of Korea. "A woman’s reproductive history could be considered in assessing her individual risk to developing thyroid cancer."
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

